The highly stable inactivated, adjuvanted vaccine against Rabies that offers complete protection.

Composition
Each dose contains ≥ 2 mouse potency I.U. of inactivated rabies virus, strain Pasteur, adjuvated with aluminiumphosfate.

Formulation
Liquid vaccine.

Indications
Vaccination against rabies.

Vaccination
A single vaccination at 12 weeks of age will protect both cats and dogs for a period of at least 3 years. If animals are vaccinated for the first time below the age of 12 weeks, there is possible interference with maternal antibodies, and for this reason, a revaccination should be performed at the age of 12 weeks or older. Vaccination with Nobivac Rabies however is part of a comprehensive vaccination programme. Several alternatives exist. (See vaccination programme for dogs, See vaccination programme for cats).

The bivalent vaccine against leptospirosis. Dogs are protected against clinical disease and also against becoming renal shedders after challenge.

Composition
Each dose contains ≥ 40 hamster PD80 inactivated bacteria of strain Ca-12-000 of L.Canicola and ≥ 40 hamster PD80 inactivated bacteria of strain 820K of L.Icterohaemorrhagiae.

Formulation
Liquid vaccine

Indications
Active immunisation against Leptospirosis caused by L.Icterohaemorrhagiae and L.Canicola of Leptospira interrogans.

Vaccination
Nobivac Lepto is indicated for a basic vaccination schedule with a first vaccination at 8-9 weeks of age, followed by a booster at 12 weeks of age, and for annual revaccination. Vaccination with Nobivac Lepto however is part of a comprehensive vaccination programme. Several alternatives exist. (See vaccination programme for dogs)

Presentation

Live vaccine containing >10^4.0 TCID₅₀ Canine distemper virus; >10^4.0 TCID₅₀ Canine adenovirus type 2; >10^7.0 TCID₅₀ Canine parvovirus, >10^5.5 TCID₅₀ Canine parainfluenzavirus per dose after reconstitution.

Uses

For active immunisation of dogs to prevent mortality and clinical signs caused by canine distemper virus infection. To reduce clinical signs of infectious hepatitis and viral excretion due to canine adenovirus type 1 infection. To prevent mortality, clinical signs and viral excretion following canine parvovirus infection. To reduce clinical signs and viral excretion caused by canine parainfluenza virus infection and to reduce clinical signs of respiratory disease and viral excretion following adenovirus type 2 infection.

Combined Freeze-Dried Canine Distemper and Parvovirus Vaccine

INDICATION
Active immunisation of young puppies against canine distemper virus, and canine parvovirus infection.

Thepuppy vaccination programme can becompleted from 10weeks of age and followingcompletion, the components of Nobivac Puppy DP have been shown to protect against canine distemper virus and canine parvovirus for at leastthree years, whilst onset of immunity is one week following administration. Puppy DP can be used at 6weeks of age followed by Nobivac DHP/DHPPi at 10 weeks of age.